DK534281A - Fremgangsmaade til fremstilling af 1-sulfo-2-oxozetidinderivater - Google Patents

Fremgangsmaade til fremstilling af 1-sulfo-2-oxozetidinderivater

Info

Publication number
DK534281A
DK534281A DK564281A DK534281A DK534281A DK 534281 A DK534281 A DK 534281A DK 564281 A DK564281 A DK 564281A DK 534281 A DK534281 A DK 534281A DK 534281 A DK534281 A DK 534281A
Authority
DK
Denmark
Prior art keywords
oxozetime
ingrediates
sulfo
preparing
procedure
Prior art date
Application number
DK564281A
Other languages
English (en)
Inventor
T Matsuno
H Masuya
N Noguchi
M Ochiai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK534281A publication Critical patent/DK534281A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK564281A 1980-12-03 1981-12-02 Fremgangsmaade til fremstilling af 1-sulfo-2-oxozetidinderivater DK534281A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1980/000293 WO1982001871A1 (en) 1980-12-03 1980-12-03 Process for preparing a 1-sulfo-2-oxoazetidine derivative

Publications (1)

Publication Number Publication Date
DK534281A true DK534281A (da) 1982-06-04

Family

ID=13706129

Family Applications (1)

Application Number Title Priority Date Filing Date
DK564281A DK534281A (da) 1980-12-03 1981-12-02 Fremgangsmaade til fremstilling af 1-sulfo-2-oxozetidinderivater

Country Status (5)

Country Link
EP (1) EP0053387A1 (da)
JP (1) JPS57118560A (da)
DK (1) DK534281A (da)
ES (1) ES507638A0 (da)
WO (1) WO1982001871A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US4883869A (en) * 1984-12-20 1989-11-28 The Upjohn Company Novel beta-lactams containing amino acid substituents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
US4224336A (en) * 1979-04-17 1980-09-23 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
CA1338538C (en) * 1979-06-08 1996-08-20 Taisuke Matsuo 1-sulfo-2-oxoazetidine derivatives and their production

Also Published As

Publication number Publication date
EP0053387A1 (en) 1982-06-09
ES8303327A1 (es) 1983-02-01
WO1982001871A1 (en) 1982-06-10
ES507638A0 (es) 1983-02-01
JPS57118560A (en) 1982-07-23

Similar Documents

Publication Publication Date Title
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK525481A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK354281A (da) Fremgangsmaade til geninkorporering af kakaoaroma
DK299483A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK489381A (da) Fremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK501781A (da) Fremgangsmaade til fremstilling af 2-oxoazetidin-derivater
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK283083D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK372081A (da) Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK115581A (da) Fremgangsmaade til fremstilling af pyrimidylquinazoliner
DK142381A (da) Fremgangsmaade til fremstilling af substituerede triarylthiazolforbindelser
DK226881A (da) Fremgangsmaade til fremstilling af 3-picolin
DK231581A (da) Fremgangsmaade til fremstilling af phenoxyaminopropanolderivater
DK371981A (da) Fremgangsmaade til fremstilling af aminoacetonitrilderivater
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783D0 (da) Fremgangsmade til fremstilling af n-phosphonometylglycin
DK449881A (da) Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater
DK399783D0 (da) Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler
DK380981A (da) Fremgangsmaade til fremstilling af benzoquinoliziner
DK411881A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactamantibiotika
DK362381A (da) Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser
DK57881A (da) Fremgangsmaade til fremstilling af benzylinderivater
DK159417C (da) Fremgangsmaade til fremstilling af alfa-ketocarboxylsyre-n-tert.butylamider
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment